aTyr Pharma, Inc. · MUN:471A

aTyr Pharma, Inc. financial statements

aTyr Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue190.0K235.0K353.0K10.4M010.5M422.0K
Cost of revenue1.55M1.54M2.74M1.70M1.30M17.3M14.0M746.0K713.0K900.0K
Gross profit-1.36M235.0K353.0K8.69M-1.30M-6.84M-13.6M-746.0K-713.0K-900.0K
Research and development60.2M54.4M42.3M42.8M23.3M17.3M14.0M20.4M30.1M42.8M
Selling, general and administrative17.6M13.8M13.0M14.0M10.8M9.07M9.35M
Operating income-77.6M-67.9M-54.9M-46.4M-34.0M-15.9M-23.0M-32.8M-47.1M-57.9M
Depreciation and amortization664.0K708.0K592.0K232.0K475.0K569.0K635.0K746.0K713.0K900.0K
EBITDA-77.0M-67.2M-54.3M-46.2M-33.5M-15.3M-22.3M-32.1M-46.4M-57.0M
Income before tax-74.1M-64.0M-50.4M-45.3M-33.8M-16.2M-23.8M-34.5M-48.2M-57.9M
Income tax00000000-49.0K
Net income-74.1M-64.0M-50.4M-45.3M-33.8M-16.2M-16.2M-34.5M-48.2M-57.9M
Earnings per share, basic-0.80-0.86-0.94-1.60-1.77-1.77-7.03-16.11-26.13-2.44
Earnings per share, diluted-0.80-0.86-0.94-1.60-1.77-1.77-7.03-16.11-26.13-2.44

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents10.7M11.1M22.5M9.98M2.34M17.0M9.21M23.0M21.1M38.4M
Short-term investments67.9M61.1M75.6M56.2M105.6M14.7M21.9M26.6M64.0M33.8M
Receivables873.0K1.74M2.44M11.8M435.0K2.04M100.0K
Current assets80.2M82.0M103.0M80.9M113.6M35.5M31.9M50.8M87.0M74.8M
Property, plant and equipment4.26M4.85M5.53M3.06M543.0K899.0K1.27M1.85M2.28M1.42M
Total assets93.0M96.8M120.7M95.8M115.5M38.7M36.2M52.7M89.4M80.5M
Accounts payable3.89M4.32M3.53M3.11M1.03M1.43M847.0K1.04M2.28M2.61M
Current liabilities15.1M15.0M16.4M13.9M6.01M5.86M12.9M10.8M10.4M8.53M
Long-term debt8.26M14.7M9.20M
Total debt12.0M13.3M15.1M11.5M1.38M2.24M8.74M16.0M19.7M9.54M
Total liabilities26.9M27.0M30.2M24.5M6.41M7.24M15.2M19.1M25.1M17.7M
Shareholders' equity67.5M70.0M90.7M71.5M109.3M31.6M21.2M33.6M64.2M62.8M
Shares outstanding2.45M84.0M63.3M29.5M27.8M11.0M3.89M2.19M29.8M23.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-62.0M-69.1M-33.2M-41.9M-33.1M-15.3M-20.0M-31.1M-42.4M-52.9M
Capital spending-77.0K-65.0K-4.21M-1.64M-192.0K-202.0K-79.0K-594.0K-1.31M-600.0K
Free cash flow-62.1M-69.2M-37.4M-43.5M-33.3M-15.5M-20.1M-31.7M-43.7M-53.5M
Cash from investing-5.05M17.2M-20.1M47.2M-91.6M6.90M4.92M37.2M-27.6M33.5M
Cash from financing66.0M39.9M66.2M5.45M110.0M16.1M1.34M-4.24M52.7M4.70M
Change in cash-1.03M-12.0M12.9M10.8M-14.6M7.74M-13.8M1.87M-17.3M-14.6M